Philippines
· Delayed Price · Currency is PHP EURO Statistics
Total Valuation
Euro-Med Laboratories Phil. has a market cap or net worth of PHP 2.92 billion. The enterprise value is 6.01 billion.
| Market Cap | 2.92B |
| Enterprise Value | 6.01B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Euro-Med Laboratories Phil. has 4.11 billion shares outstanding.
| Shares Outstanding | 4.11B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -17.96% |
| Owned by Insiders (%) | 3.48% |
| Owned by Institutions (%) | 5.62% |
| Float | 711.14M |
Valuation Ratios
The trailing PE ratio is 9.02.
| PE Ratio | 9.02 |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| PB Ratio | 0.49 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.94, with an EV/FCF ratio of -40.13.
| EV / Earnings | 18.57 |
| EV / Sales | 1.07 |
| EV / EBITDA | 5.94 |
| EV / EBIT | 8.40 |
| EV / FCF | -40.13 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 72.07.
| Current Ratio | 1.36 |
| Quick Ratio | 0.76 |
| Debt / Equity | 72.07 |
| Debt / EBITDA | 4.24 |
| Debt / FCF | -28.67 |
| Interest Coverage | 2.45 |
Financial Efficiency
Return on equity (ROE) is 5.51% and return on invested capital (ROIC) is 4.56%.
| Return on Equity (ROE) | 5.51% |
| Return on Assets (ROA) | 4.27% |
| Return on Capital (ROIC) | 4.56% |
| Revenue Per Employee | 3.51M |
| Profits Per Employee | 201,819 |
| Employee Count | 1,604 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.17 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.79% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -7.79% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 42.77 |
| Average Volume (20 Days) | 46,950 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Euro-Med Laboratories Phil. had revenue of PHP 5.63 billion and earned 323.72 million in profits. Earnings per share was 0.08.
| Revenue | 5.63B |
| Gross Profit | 2.01B |
| Operating Income | 715.67M |
| Pretax Income | 442.42M |
| Net Income | 323.72M |
| EBITDA | 951.76M |
| EBIT | 715.67M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 1.20 billion in cash and 4.29 billion in debt, giving a net cash position of -3.09 billion or -0.75 per share.
| Cash & Cash Equivalents | 1.20B |
| Total Debt | 4.29B |
| Net Cash | -3.09B |
| Net Cash Per Share | -0.75 |
| Equity (Book Value) | 5.96B |
| Book Value Per Share | 1.45 |
| Working Capital | 1.40B |
Cash Flow
In the last 12 months, operating cash flow was 160.26 million and capital expenditures -310.01 million, giving a free cash flow of -149.75 million.
| Operating Cash Flow | 160.26M |
| Capital Expenditures | -310.01M |
| Free Cash Flow | -149.75M |
| FCF Per Share | -0.04 |
Margins
Gross margin is 35.65%, with operating and profit margins of 12.71% and 5.75%.
| Gross Margin | 35.65% |
| Operating Margin | 12.71% |
| Pretax Margin | 7.85% |
| Profit Margin | 5.75% |
| EBITDA Margin | 16.90% |
| EBIT Margin | 12.71% |
| FCF Margin | -2.66% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 4.93%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 4.93% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 44.46% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.93% |
| Earnings Yield | 11.09% |
| FCF Yield | -5.13% |
Stock Splits
The last stock split was on July 5, 2011. It was a forward split with a ratio of 1.07.
| Last Split Date | Jul 5, 2011 |
| Split Type | Forward |
| Split Ratio | 1.07 |